Duopharma Biotech was testing the RM1.38 mark in its latest session. With a neutral RSI above 50%, a bullish bias may be present above this point with a target price of RM1.48, followed by RM1.57. If it fails to cross the RM1.38, it will continue to move sideways and consolidates. The support level is anticipated at RM1.29 whereby traders may exit on a breach to avoid the risk of a further correction.

Trading Call: Buy upon breakout above RM1.38

Target: RM1.48, RM1.57 (time frame: 3–6 weeks)

Exit: RM1.29

Source: AmInvest Research - 24 Apr 2019